Skip to main content
Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
36.38
-0.16 (-0.44%)
At close: Dec 5, 2025, 4:00 PM EST
37.29
+0.91 (2.50%)
After-hours: Dec 5, 2025, 7:56 PM EST

Ultragenyx Pharmaceutical Revenue by Segment
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Product
321.49M 314.47M 285.47M 265.30M 230.30M 198.70M 180.40M 157.60M
Product Growth
39.59% 58.26% 58.24% 68.34% 55.82% 45.67% 51.72% 43.01%
Other
288.69M 276.21M 274.71M 257.40M 250.90M 243.80M 253.80M 252.60M
Other Growth
15.06% 13.29% 8.24% 1.90% 2.37% 2.65% 8.28% 13.27%

Revenue by Geography
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
North America
354.58M 340.56M 340.46M 316.40M 307.30M 297.70M 307.10M 299.00M
North America Growth
15.39% 14.40% 10.86% 5.82% 3.05% 4.02% 9.29% 11.94%
Latin America
144.47M 150.40M 130.71M 130.30M 109.50M 89.70M 77.30M 67.40M
Latin America Growth
31.93% 67.67% 69.10% 93.32% 70.30% 55.46% 72.93% 61.24%
Europe
97.65M 87.45M 80.12M 69.60M 60.40M 54.20M 47.60M 42.70M
Europe Growth
61.68% 61.35% 68.33% 63.00% 58.53% 44.15% 30.77% 28.61%
Japan
12.89M 9.69M - 7.60M 6.50M - - - - - - - - - - - - - - -
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.